TNFA

TNFA

USD

TNF Pharmaceuticals Inc. Common Stock

$5.200-0.430 (-7.638%)

Reaalajas hind

Tehnoloogia
Arvutiriistvara
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$5.630

Kõrge

$8.900

Madal

$4.200

Maht

0.52M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

9.6M

Tööstusharu

Arvutiriistvara

Riik

United States

Kauplemisstatistika

Keskmine maht

1.82M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $3.24Praegune $5.200Kõrge $195

Seotud uudised

BusinessWire

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol "QCLS"

Licensed technology positions Company at forefront of new quantum-class computing paradigm

Vaata rohkem
Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol "QCLS"
BusinessWire

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol "QCLS" to Reflect Strategic Focus on Quantum Class Photonic Computing

New trading symbol QCLS effective Thursday, September 25, 2025 Licensed technology positions Company at forefront of new quantum-class computing paradigm TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) ("Q/C" or the

Vaata rohkem
TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol "QCLS" to Reflect Strategic Focus on Quantum Class Photonic Computing
BusinessWire

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

TNF Pharmaceuticals Inc. (NASDAQ:TNFA), ("TNF" or the "Company") today announced that it received written notice from the Nasdaq Stock Market on September 16, 2025, confirming that the Company has regained compliance

Vaata rohkem
TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
BusinessWire

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Management to present on Wednesday, September 10, 2025, at 8:00 a.m. ET TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) ("TNF" or the "Company") today announced its participation in the H.C. Wainwright & Co. 27th Annual

Vaata rohkem
TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.